See also this year's filing and all EDGAR filings for this company.
PDF Report 0000858803_2015_Avanir_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000858803, Avanir Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 300,817,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,631,000 |
| 3 | remainder_Assets | 2,535,000 |
| 4 | LiabilitiesCurrent | 32,093,000 |
| 5 | LiabilitiesNoncurrent | 1,501,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,191,000 |
| 9 | ResearchAndDevelopmentExpense | 44,004,000 |
| 10 | remainder_Expenses | 84,493,000 |
| 11 | remainder_Revenues | 115,029,000 |
| 12 | remainder_NetIncome | -777,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 306,983,000 |
| 1 | Liabilities | 33,594,000 |
| 2 | Expenses | 164,688,000 |
| 3 | Revenues | 115,029,000 |
| 4 | StockholdersEquity | 273,389,000 |
| 5 | NetIncome | -50,436,000 |
| 6 | ComprehensiveNetIncome | -50,436,000 |
| 7 | BaseVar | 310,535,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.20 |
| 9 | EconomicCapitalRatio | 3.82 |
Edgar->Model Mapping
Feature Distribution
Change over Time
